FOR CLINICIANS
Treatment Guidelines for Medical Providers
Hidradenitis Suppurativa is a chronic, debilitating, inflammatory disease, which affects up to 1% of the U.S. population. The following guidelines are based on current evidence and practice trends, emphasizing the role of dermatologists in treatment recommendations.
Access the full hidradenitis suppurativa guideline from JAAD (free):
- Part I: Diagnosis, evaluation, and the use of complementary and procedural management
- Part II: Topical, intralesional, and systemic medical management
- Supplemental Materials: Background and recommendations regarding use of systemic antibiotics, biologics, and systemic retinoids for Hidradenitis Suppurativa
Publications on HS
Find Hidradenitis Suppurativa publications in the National Library of Medicine.
Hidradenitis Suppurativa: Diagnosis and Management in the Emergency Department
Authors: Martin Okun, MD, PhD; Avram Flamm, DO; Elizabeth Barrall Werley, MD, Joslyn Kirby, MD, MS, MEd
Journal of Emergency Medicine: August 12, 2022 Open Access
doi: 10.1016/j.jemermed.2022.08.001
A Comprehensive Guide to Hidradenitis Suppurativa, 1st Edition
Authors: Vivian Y. Shi, MD; Jennifer L. Hsiao, MD; Michelle Lowes, MBBS, PhD; Iltefat Hamzavi, MD
Diagnosing and Managing Hidradenitis Suppurativa in Pediatrics
Authors: Erin Collier, MD; Muskaan Sachdeva, BHSc; Shahram Yazdani, MD; Marcia Hogeling, MD; Martin Okun, MD; Haley Naik, MD, Michelle Lowes, MBBS, PhD, Jennifer Hsiao, MD; and Vivian Shi, MD.
Pediatric Annals: Volume 51, No. 3, 2022
doi: 10.3928/19382359-20220222-02
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts
Authors: Vivian Shi, MD; Afsaneh Alavi, MD; Haley Naik, MD; John Frew, MBBS, MMed, Joslyn Kirby, MD; Christopher Sayed, MD; Jennifer Hsaio, MD; Devea De, MD, Jonathan Rick, MD; and Terri Shih, MD.
Skin Appendage Disorders Research Article: January 2022
doi: 10.1159/000521268
Biologic Therapy is not Associated with Increased COVID-19 Severity in Patients with Hidradenitis Suppurativa: Initial Findings from the Global Hidradenitis Suppurativa COVID-19 Registry
Authors: Haley B. Naik, MD, MHSc; Raed Alhusayen, MBBS, MSCE, FAAD; John Frew, MBBS, MMed, MSc, FACD; Sandra Guilbault, BS; Nancy K. Hills, PhD; John R. Ingram, MRCP, MSc, FRCP; Margaret V. Kudlinkski, BS; Michelle A. Lowes, MBBS, Phd, FACD; Angelo Valerio Marzano, MD; Maia Paul, MPH; Bente Villumsen, MSc; Christine A. Yannuzzi, BA
Journal of the American Academy of Dermatology: January 2022 - Volume 86 - Issue 1 - p249-252
doi: 10.1016/j.jaad.2021.09.016
Diagnosis and Management of Hidradenitis Suppurativa in Women
Authors: Erin K. Collier, MPH; Ram K. Parvateneni, MD, MPH; Michelle A Lowes, MBBS, PhD, Haley B. Naik, MD, MHSc; Martin M. Okun, MD, PhD, Vivian Y. Shi, MD; Jennifer L. Hsiao, MD
Obstetrics & Gynecology: January 2021 - Volume 224 - Issue 1 - p54-61
doi: 10.1016/j.ajog.2020.09.036
Plastic Surgical Management of Hidradenitis Suppurativa
Authors: Erin M. Taylor, MD; Ryoko Hamaguchi, BS; Kimberly M. Kramer, MPH; Alexa B. Kimball, MD, MPH; Dennis P. Orgill, MD, PhD
American Society of Plastic Surgeons:
doi: 10.1097/PRS.0000000000007677
Clinical Epidemiology and Management of Hidradenitis Suppurativa
Authors: Christopher J. Sayed, MD; Jennifer L. Hsiao, MD; Martin M. Okun, MD, PhD; for the Hidradenitis Suppurativa Foundation Women's Health Subcommittee
Obstetrics & Gynecology: April 2021 - Volume 137 - Issue 4 - p 731-746
doi: 10.1097/AOG.0000000000004321
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
Authors: Amit Garg, MD; Neeta Malviya, MD; Andrew Strunk, MA; Shari Wright, BS; Afsaneh Alavi, MD; Raed Alhusayen, MBBS, MSCE, FRCPC; Ali Alikhan, MD; Steven D. Daveluy, MD; Isabelle Delorme, MD, FRCPC; Noah Goldfarb, MD; Wayne Gulliver, MD; Iltefat Hamzavi, MD; Tarannum Jaleel, MD; Alexa B. Kimball, MD, MPH; Joslyn S. Kirby, MD, MEd, MS; Mark G. Kirchhof, MD, PhD, FRCPC; Janice Lester, MLIS; Hadar Lev-Tov, MD; Michelle A. Lowes, MD, PhD; Robert Micheletti, MD; Lauren A. Orenstein, MD; Vincent Piguet, MD, PhD, FRCP; Christopher Sayed, MD; Jerry Tan, MD, FRCP; Haley B. Naik, MD, MHSc
Journal of the American Academy of Dermatology
doi: https://doi.org/10.1016/j.jaad.2021.01.059
Downloads
Facts about Hidradenitis Suppurativa (HS) Pamphlet:
